NCT05855278View on ClinicalTrials.gov

The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 13, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Esophageal Cancer
Interventions
DIAGNOSTIC_TEST

PET/MRI

The participants receive 18F-FDG PET/MRI before and during definitive chemoradiotherapy.

Trial Locations (1)

Unknown

Linkou Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT05855278 - The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer Patients | Biotech Hunter | Biotech Hunter